From breakthrough cosmetics to advanced gastrointestinal health therapies, Zyme Fast delivers biotech innovations that last for generations.
Years of industry experience
Break-through products in our portfolio
Years of innovation in biotech
Zyme Fast Inc. is at the forefront of biotechnology since 2001, creating transformative solutions that combat gastrointestinal pathogens, revolutionize skin health, and enhance animal nutrition. By merging cutting-edge recombinant technology with unmatched efficiency, we’re shaping the future of global health.
Bridging the gap between human health, cosmetics, and animal nutrition with advanced innovative biotech.
Our human health line includes groundbreaking products to combat severe gastrointestinal infections including:
Through our subsidiary in Changsha, China, we provide animal feed additives that enhance growth and immunity without the use of antibiotics, offering a sustainable solution for large-scale farming. This division includes virus-targeted products, immune support, and appetite enhancers, supporting healthier livestock and higher yields.
This divisions’ products include bacterium and virus-targeted products and appetite enhancers that support healthier livestock with higher yields and lower costs.
Zyme Fast Inc. is at the forefront of biotechnology since 2001, creating transformative solutions that combat gastrointestinal pathogens.
Our proprietary production techniques reduce costs by up to 99%, offering unmatched pricing for high-demand molecules.
With established facilities in Canada and China, Zyme Fast serves North American, Asian, and European markets.
Zyme Fast holds exclusive EYA-based solutions for C. diff, E. coli, and H. pylori, poised to solidify our place as industry leaders.
CEO Stan Schroeder and CSO Dr. Lin Fang bring a combined 75+ years of experience in biotech and strategic growth, paving the way for sustained innovation and expansion.
Innovative products harness the power of recombinant technologies
Advanced formulations for long-lasting disease prevention.
R&D lab and headquarters in Manitoba, supporting North American market operations.
Located in Changsha, it includes a state-of-the-art egg processing plant capable of handling one million eggs per day. Certified for quality (ISO9001:2008) and food safety, Zyme Fast China produces antibody-rich products for animal health and pet markets.
CEO & President
With 40+ years of leadership in national and international sales, Stan Schroeder steers Zyme Fast’s vision, focusing on new market strategies and company growth.
Chief Science Officer
Dr. Fang, a biotech pioneer, has spearheaded the development of 25+ protein-based products and oversees all R&D at Zyme Fast.